Evidence map›Paper›PMID 32161356›Full record

ArticleScientific reports2020

Sertraline induces DNA damage and cellular toxicity in Drosophila that can be ameliorated by antioxidants.

Arpita Jajoo, Catherine Donlon, Sarah Shnayder, Michael Levin, Mitch McVey

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Arpita Jajoo *Department of Biology, Tufts University, Medford, MA, USA.ORCID http://orcid.org/0000-0003-0430-694X
Catherine Donlon *Department of Biology, Tufts University, Medford, MA, USA.
Sarah ShnayderDepartment of Biology, Tufts University, Medford, MA, USA.
Michael LevinDepartment of Biology, Tufts University, Medford, MA, USA.ORCID http://orcid.org/0000-0001-7292-8084
Mitch McVeyDepartment of Biology, Tufts University, Medford, MA, USA. mitch.mcvey@tufts.edu.ORCID http://orcid.org/0000-0001-8883-0188
Tufts University · US

Funding

Mutations Arising During DNA RepairP01GM105473 · NIGMS · BRANDEIS UNIVERSITY · PI LOVETT, SUSAN THOMAS · 2014 to 2018
$8.6M
NIGMS NIH HHS P01 GM105473
6 · The paper itself

Abstract

Sertraline hydrochloride is a commonly prescribed antidepressant medication that acts by amplifying serotonin signaling. Numerous studies have suggested that children of women  taking sertraline during pregnancy have an increased risk of developmental defects. Resolving the degree of risk for human fetuses requires comprehensive knowledge of the pathways affected by this drug. We utilized a Drosophila melanogaster model system to assess the effects of sertraline throughout development. Ingestion of sertraline by females did not affect their fecundity or embryogenesis in their progeny. However, larvae that consumed sertraline experienced delayed developmental progression and reduced survival at all stages of development. Genetic experiments showed that these effects were mostly independent of aberrant extracellular serotonin levels. Using an ex vivo imaginal disc culture system, we showed that mitotically active sertraline-treated tissues accumulate DNA double-strand breaks and undergo apoptosis at increased frequencies. Remarkably, the sertraline-induced genotoxicity was partially rescued by co-incubation with ascorbic acid, suggesting that sertraline induces oxidative DNA damage. These findings may have implications for the biomedicine of sertraline-induced birth defects.

Indexed as

AnimalsAntioxidantsApoptosisDietary SupplementsDNA DamageDrosophilaDrug AntagonismLarvaSelective Serotonin Reuptake InhibitorsSertralineAntioxidantsSelective Serotonin Reuptake InhibitorsSertraline

Identifiers

PMID32161356
PMCPMC7066164
OpenAlexW3011775146

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.